Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

STAT+: Pharmalittle: We’re reading about Roche investments in Germany, a Gilead bowel disease drug, and more

Roche is reviewing all future investments in Germany over health care cost-cutting policies, with a top executive citing a loss of trust

STAT+: Pharmalittle: We’re reading about Roche investments in Germany, a Gilead bowel disease drug, and more

We haven't written up this one. STAT News has the full story — the link below goes straight to it.

Read the original at statnews.com →

More in Health & Medicine

More from Monday 19 October →